Abstract:
When making a diagnosis by synthetically taking into account the information obtained by preparing a plurality of samples using different staining methods or the like and sequentially observing the samples, a diagnostician must remember information about the plurality of samples.The present invention includes image storage means for storing a reference image obtained by photographing a predetermined stained sample of and a comparison image obtained by photographing another stained sample of substantially identical biological tissues, partial image creation means for detecting a structure of the biological tissue from the reference image, cutting out from the comparison image a partial image that contains the structure detected, and storing into partial image storage means the partial image in association with the structure and the comparison image, image output means for outputting a result image that includes the reference image and the partial image, and the partial image storage means.
Abstract:
As a technique enabling to simply and accurately diagnose human T cell leukemia virus type 1 (HTLV-1) related disease, there is provided a diagnostic method for an HTLV-1 related disease based on an amount of tumor necrosis factor receptor 2 (TNFR2) in a blood sample taken from a subject, wherein (1) it is determined based on an increase of the amount of TNFR2 that the subject suffers from, or is likely to develop, the HTLV-1 related disease; and/or (2) it is determined based on a decrease of the amount of TNFR2 that the subject is in remission, or is likely to be in remission, of the HTLV-1 related disease.
Abstract:
Luminance calculation means 81 calculates luminance of a cell nucleus extracted from an antinuclear antibody image of a designated dilution ratio. Titer prediction means 82 predicts an antinuclear antibody titer, using a staining pattern specified from a staining form of the cell nucleus and the luminance at at least one dilution ratio.
Abstract:
As a technique enabling to simply and accurately diagnose human T cell leukemia virus type 1 (HTLV-1) related disease, there is provided a diagnostic method for an HTLV-1 related disease, comprising the steps of: measuring the amount of a marker protein in a blood sample taken from a subject, wherein the marker protein is at least one selected from the proteins listed in Tables 1 and 2; and, if a measured value is a predetermined reference value or more or the predetermined reference value or less, determining that the subject suffers from the HTLV-1 related disease or determining that the subject is in remission of the HTLV-1 related disease.
Abstract:
A method of ranking epitopes derived from neoantigens as targets for personalized immunotherapy includes collecting candidate epitopes based on patient data of a cancer patient. A set of scores are calculated for each of the candidate epitopes, each of the scores in a respective one of the sets for a respective one of the candidate epitopes representing an independent measure of a likelihood of the respective one of candidate epitopes to elicit an immune response in the cancer patient. The scores in each of the sets of scores are combined into a single score for each of the candidate epitopes. The single scores for the candidate epitopes in each case reflect an overall likelihood of eliciting the immune response in the patient. The candidate epitopes are ranked using the single scores for the immunotherapy.
Abstract:
An information processing apparatus (2000) extracts a histomorphological feature of a tissue included in pathological image data (10). The information processing apparatus (2000) generates prediction data (30) based on the extracted histomorphological feature. The prediction data (30) indicates one or more of a prediction relating to an effect of a cancer therapeutic drug on a target patient and a prediction of a side effect of the cancer therapeutic drug on the target patient.